$VCYT
VERACYTE, INC. Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000110465914037094 Filed on May 09, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q4
Revenue	$8.680M	$7.476M	$6.838M
YoY Change	71.27%	70.53%	53.42%
Cost Of Revenue	$3.970M	$3.607M	$3.470M
YoY Change	22.91%	30.08%	33.46%
Gross Profit	$4.710M	$3.869M	$3.370M
YoY Change	155.98%	140.16%	81.18%
Gross Profit Margin	54.26%	51.75%	49.28%
Selling, General & Admin	$9.030M	$8.318M	$7.260M
YoY Change	68.79%	51.4%	38.29%
% of Gross Profit	191.72%	214.99%	215.43%
Research & Development	$2.240M	$2.126M	$1.870M
YoY Change	17.89%	5.77%	8.72%
% of Gross Profit	47.56%	54.95%	55.49%
Depreciation & Amortization	$280.0K	$264.0K	$280.0K
YoY Change	21.74%	34.01%	55.56%
% of Gross Profit	5.94%	6.82%	8.31%
Operating Expenses	$11.27M	$14.05M	$9.130M
YoY Change	55.23%	36.72%	30.99%
Operating Profit	-$6.560M	-$6.575M	-$5.760M
YoY Change	21.03%	11.57%	12.72%
Interest Expense	-$110.0K	$111.0K	-$100.0K
YoY Change	1000.0%
% of Operating Profit
Other Income/Expense, Net	$20.00K	$12.00K	-$30.00K
YoY Change	-101.87%	-101.2%	-110.71%
Pretax Income	-$6.660M	-$6.670M	-$5.890M
YoY Change	2.62%	-3.33%	21.69%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$6.660M	-$6.670M	-$5.892M
YoY Change	2.62%	-3.26%	21.81%
Net Earnings / Revenue	-76.73%	-89.22%	-86.17%
Basic Earnings Per Share
Diluted Earnings Per Share	-$313.6K	-$315.4K	-$281.4K
COMMON SHARES
Basic Shares Outstanding	21.17M shares	21.14M shares	21.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.00M	$64.20M	$71.20M
YoY Change	180.19%	804.23%
Cash & Equivalents	$58.00M	$64.24M	$71.22M
Short-Term Investments
Other Short-Term Assets	$1.500M	$1.000M	$1.500M
YoY Change	7.14%	11.11%
Inventory	$3.300M	$2.721M	$2.567M
Prepaid Expenses
Receivables	$1.400M	$1.191M	$1.143M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$64.20M	$69.16M	$76.41M
YoY Change	169.75%	660.03%	366.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.300M	$3.028M	$2.952M
YoY Change	10.0%	8.14%	20.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$300.0K	$145.0K	$153.0K
YoY Change	0.0%	-27.5%	25.41%
Total Long-Term Assets	$3.600M	$3.291M	$3.223M
YoY Change	5.88%	6.16%	19.99%
TOTAL ASSETS
Total Short-Term Assets	$64.20M	$69.16M	$76.41M
Total Long-Term Assets	$3.600M	$3.291M	$3.223M
Total Assets	$67.80M	$72.45M	$79.63M
YoY Change	149.26%	493.89%	317.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.500M	$7.214M	$5.294M
YoY Change	347.37%	324.35%	180.4%
Accrued Expenses	$5.100M	$5.267M	$7.594M
YoY Change	-5.56%	64.59%	88.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$900.0K	$467.0K
YoY Change
Total Short-Term Liabilities	$17.10M	$15.45M	$15.39M
YoY Change	74.49%	73.57%	71.15%
LONG-TERM LIABILITIES
Long-Term Debt	$4.000M	$4.467M	$4.899M
YoY Change	-16.67%
Other Long-Term Liabilities	$1.600M	$2.200M	$2.900M
YoY Change	-62.79%	-52.17%
Total Long-Term Liabilities	$5.600M	$4.467M	$4.899M
YoY Change	-38.46%	-2.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.10M	$15.45M	$15.39M
Total Long-Term Liabilities	$5.600M	$4.467M	$4.899M
Total Liabilities	$22.70M	$22.16M	$23.19M
YoY Change	20.11%	64.18%	63.68%
SHAREHOLDERS EQUITY
Retained Earnings		-$92.32M	-$85.65M
YoY Change			42.58%
Common Stock		$142.6M	$142.1M
YoY Change			8791.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$45.00M	$50.29M	$56.44M
YoY Change
Total Liabilities & Shareholders Equity	$67.80M	$72.45M	$79.63M
YoY Change	149.26%	493.89%	317.63%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q4
OPERATING ACTIVITIES
Net Income	-$6.660M	-$6.670M	-$5.892M
YoY Change	2.62%	-3.26%	21.81%
Depreciation, Depletion And Amortization	$280.0K	$264.0K	$280.0K
YoY Change	21.74%	34.01%	55.56%
Cash From Operating Activities	-$5.900M	-$6.760M	-$3.300M
YoY Change	47.5%	2.11%	-15.17%
INVESTING ACTIVITIES
Capital Expenditures	-$780.0K	$124.0K	-$270.0K
YoY Change	105.26%	-77.7%	-50.91%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$780.0K	-$120.0K	-$270.0K
YoY Change	105.26%	-76.47%	-50.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	450.0K	-100.0K	59.36M
YoY Change	-97.5%	-150.0%	295.73%
NET CHANGE
Cash From Operating Activities	-5.900M	-6.760M	-3.300M
Cash From Investing Activities	-780.0K	-120.0K	-270.0K
Cash From Financing Activities	450.0K	-100.0K	59.36M
Net Change In Cash	-6.230M	-6.980M	55.79M
YoY Change	-145.74%	0.72%	428.31%
FREE CASH FLOW
Cash From Operating Activities	-$5.900M	-$6.760M	-$3.300M
Capital Expenditures	-$780.0K	$124.0K	-$270.0K
Free Cash Flow	-$5.120M	-$6.884M	-$3.030M
YoY Change	41.44%	-4.07%	-9.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Inventory Net InventoryNet	2721000	USD
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of the unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; contractual allowances; allowance for doubtful accounts; the useful lives of property and equipment; the recoverability of long-lived assets; the determination of fair value of the Company’s common stock prior to the Company’s initial public offering (“IPO”), stock options, preferred stock liability; income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</font></p> </div>
CY2014Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2014Q1	vcyt	Number Of Major Financial Institutions With Which Cash And Cash Equivalents Deposited NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited	1	institution
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	118000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	118000	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	118000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	118000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	107000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	222000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	135000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	109000	USD
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	224000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	76000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12000	USD
CY2014Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	262000	USD
CY2013Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1100000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6674000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6895000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7594000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21148342	shares
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	763021	shares
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-9.04
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3166419	shares
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	118000	USD
CY2014Q1	us-gaap	Security Deposit SecurityDeposit	75000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	989000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	413000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	222000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	130000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2466000	USD
CY2014Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	213000	USD
CY2013Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	216000	USD
CY2014Q1	us-gaap	Purchase Obligation PurchaseObligation	196000	USD
CY2014Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	196000	USD
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5000000	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	75000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15584229	shares
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1095000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1962000	USD
CY2014Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2776000	USD
CY2013Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4915000	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1396000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	717000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5267000	USD
CY2014Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21172326	shares
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64237000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71220000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1191000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1143000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	4384000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	2567000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1014000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1477000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	69163000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	76407000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3028000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2952000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	145000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	153000	USD
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	7476000	USD
CY2014Q1	us-gaap	Assets Assets	72454000	USD
CY2013Q4	us-gaap	Assets Assets	79630000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7214000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5294000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2500000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2500000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15448000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15388000	USD
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4467000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4899000	USD
CY2014Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	260000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	286000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1989000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2614000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	22164000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	23187000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	142592000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	142071000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92323000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85649000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	50290000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	56443000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72454000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79630000	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21164410	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21143313	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21164410	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21143313	shares
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	3607000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	2773000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2126000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2010000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4336000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2703000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3982000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2791000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	14051000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	10277000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6575000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5893000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	111000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1002000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	197000	USD
CY2014Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	625000	USD
CY2013Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	625000	USD
CY2014Q1	vcyt	Share Based Compensation Non Bonus Related ShareBasedCompensationNonBonusRelated	492000	USD
CY2013Q1	vcyt	Share Based Compensation Non Bonus Related ShareBasedCompensationNonBonusRelated	204000	USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	26000	USD
CY2014Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	20000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	154000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-313000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-463000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	144000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-14000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2045000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-187000	USD
CY2014Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	-2563000	USD
CY2013Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	-603000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6757000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6619000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	124000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	556000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-50000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-124000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-506000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	247000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-102000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	195000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6983000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6930000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14002000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7072000	USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7358	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3166419	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2359287	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2104032	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2994431	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.23
CY2014Q1	vcyt	Voting Rights For Each Share Of Stock VotingRightsForEachShareOfStock	1	vote
CY2014Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2013Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4171890	shares
CY2014Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4139731	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	973312	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1787802	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	850092	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35602	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.07
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.05
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.06
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.69
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.88
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.04
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M2D
CY2014Q1	vcyt	Payments Of Stock Issuance Costs Initial Public Offering PaymentsOfStockIssuanceCostsInitialPublicOffering	129000	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	29984000	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M2D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M29D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y11D
CY2014Q1	us-gaap	Share Price SharePrice	17.13
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26964000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34652000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	33330000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.27
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.71
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.37
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.07
CY2014Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	2.53
CY2013Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.87
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	500000	USD
CY2011Q2	vcyt	Collaborative Arrangement Payment Received CollaborativeArrangementPaymentReceived	100000	USD
CY2013Q1	vcyt	Income Taxes Period For Which Research Tax Credit Extended For Qualified Research Expenditures Incurred Through End Of Specified Period IncomeTaxesPeriodForWhichResearchTaxCreditExtendedForQualifiedResearchExpendituresIncurredThroughEndOfSpecifiedPeriod	P2Y
CY2014Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2014Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000	USD
CY2014Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2013Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2013Q1	vcyt	Payments Of Stock Issuance Costs Convertible Preferred Stock PaymentsOfStockIssuanceCostsConvertiblePreferredStock	52000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	712000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10000000	USD
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	467000	USD
CY2013Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-1002000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	93000	USD

Files In Submission

Name	View Source	Status
0001104659-14-037094-index-headers.html	Edgar Link	pending
0001104659-14-037094-index.html	Edgar Link	pending
0001104659-14-037094.txt	Edgar Link	pending
0001104659-14-037094-xbrl.zip	Edgar Link	pending
a14-10753_110q.htm	Edgar Link	pending
a14-10753_1ex31d1.htm	Edgar Link	pending
a14-10753_1ex31d2.htm	Edgar Link	pending
a14-10753_1ex32d1.htm	Edgar Link	pending
a14-10753_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-20140331.xml	Edgar Link	completed
vcyt-20140331.xsd	Edgar Link	pending
vcyt-20140331_cal.xml	Edgar Link	unprocessable
vcyt-20140331_def.xml	Edgar Link	unprocessable
vcyt-20140331_lab.xml	Edgar Link	unprocessable
vcyt-20140331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
VERACYTE, INC. Stock $vcyt

2014 Q2 Form 10-Q Financial Statement

#000110465914037094 Filed on May 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT VERACYTE, INC. Stock $vcyt

2014 Q2 Form 10-Q Financial Statement

#000110465914037094 Filed on May 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
VERACYTE, INC. Stock $vcyt